Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (61-70 of 408) with videos related to

Pageof 41
Sort By:
Cardiovascular Diabetology|July 5, 2022
Liver function markers predict cardiovascular and renal outcomes in the CANVAS ProgramGiulia Ferrannini, Norman Rosenthal, Michael K Hansen, et al.
Diabetes, Obesity & Metabolism|February 6, 2020
Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysisNiki Katsiki, Richard Ofori-Asenso, Ele Ferrannini, et al.
Diabetologia|June 16, 2023
Sarah A. Hills RGN MSc, 28 September 1960-1 May 2023Andrew J M Boulton, Ele Ferrannini, Philippe A Halban
Recenti Progressi in Medicina|April 26, 2011
[Bariatric surgery as a treatment of type 2 diabetes]Stefania Camastra, Chiara Chiellini, Roberta Petz, et al.
JCI Insight|December 21, 2018
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescentsDomenico Tricò, Andrea Natali, Silva Arslanian, et al.
Diabetes Research and Clinical Practice|July 8, 2022
Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetesDomenico Tricò, Francesco Raggi, Mariarosaria Distaso, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetesEle Ferrannini, Elisabeth Niemoeller, Terry Dex, et al.
The British Journal of Nutrition|March 10, 2011
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetesStephanie Madec, Valentina Corretti, Eleonora Santini, et al.
Hypertension (Dallas, Tex. : 1979)|January 17, 2018
Hypertension and Diabetes Mellitus: Coprediction and Time TrajectoriesVasilis Tsimihodimos, Clicerio Gonzalez-Villalpando, James B Meigs, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysisEleonora Grespan, Annamaria Guolo, Elza Muscelli, et al.
Pageof 41

Showing results (61-70 of 408) with videos related to

Sort By:
Pageof 41
Cardiovascular Diabetology|July 5, 2022
Liver function markers predict cardiovascular and renal outcomes in the CANVAS ProgramGiulia Ferrannini, Norman Rosenthal, Michael K Hansen, et al.
Diabetes, Obesity & Metabolism|February 6, 2020
Fixed-dose combination of empagliflozin and linagliptin for the treatment of patients with type 2 diabetes mellitus: A systematic review and meta-analysisNiki Katsiki, Richard Ofori-Asenso, Ele Ferrannini, et al.
Diabetologia|June 16, 2023
Sarah A. Hills RGN MSc, 28 September 1960-1 May 2023Andrew J M Boulton, Ele Ferrannini, Philippe A Halban
Recenti Progressi in Medicina|April 26, 2011
[Bariatric surgery as a treatment of type 2 diabetes]Stefania Camastra, Chiara Chiellini, Roberta Petz, et al.
JCI Insight|December 21, 2018
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescentsDomenico Tricò, Andrea Natali, Silva Arslanian, et al.
Diabetes Research and Clinical Practice|July 8, 2022
Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetesDomenico Tricò, Francesco Raggi, Mariarosaria Distaso, et al.
Diabetes, Obesity & Metabolism|March 8, 2022
Fixed-ratio combination of insulin glargine plus lixisenatide (iGlarLixi) improves ß-cell function in people with type 2 diabetesEle Ferrannini, Elisabeth Niemoeller, Terry Dex, et al.
The British Journal of Nutrition|March 10, 2011
Effect of a fatty meal on inflammatory markers in healthy volunteers with a family history of type 2 diabetesStephanie Madec, Valentina Corretti, Eleonora Santini, et al.
Hypertension (Dallas, Tex. : 1979)|January 17, 2018
Hypertension and Diabetes Mellitus: Coprediction and Time TrajectoriesVasilis Tsimihodimos, Clicerio Gonzalez-Villalpando, James B Meigs, et al.
The Journal of Clinical Endocrinology and Metabolism|April 9, 2022
Loss of the Incretin Effect in Type 2 Diabetes: A Systematic Review and Meta-analysisEleonora Grespan, Annamaria Guolo, Elza Muscelli, et al.
Pageof 41